Wound Additives in Primary Total Joint Athroplasty
The Effects of Platelet-Rich Plasma and Activated Collagen on Wound Healing in Primary Total Joint Arthroplasty
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
3 cohorts of total joint patient of 30 members each were randomized to receive PRP or Activated Collegen or no additive were studied for status of the wound at 6 weeks and recorded all complications, infections and reoperations. The three groups were than compared for statistical analysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2016
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2016
CompletedFirst Submitted
Initial submission to the registry
May 15, 2017
CompletedFirst Posted
Study publicly available on registry
May 18, 2017
CompletedMay 18, 2017
May 1, 2017
8 months
May 15, 2017
May 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound Status
wound hematoma, dehiscence, superficial infection
6 weeks post operative
Study Arms (2)
Platelet Rich Plasma
EXPERIMENTAL30cc of PRP was administered at closure of wound
Cellerate (Activated Collegen)
EXPERIMENTAL1gm of Cellerate was administered at closure of wound
Interventions
Eligibility Criteria
You may qualify if:
- Osteoathritis of knee and hip
You may not qualify if:
- Inflammatory arthritis and hypercoagulable state
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- computer generated randomization
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2017
First Posted
May 18, 2017
Study Start
April 1, 2016
Primary Completion
December 6, 2016
Study Completion
December 20, 2016
Last Updated
May 18, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share
no plan on sharing data